HSPA5 and cervical cancer: Additionally, a distinctive aspect observed in cervical cancer models is that overexpression of GRP78 in cervical cancer (CVC) exhibits dual influences on cisplatin responsiveness, affecting both resistance and sensitization [113, 114].